Each cell in the body possesses hundreds to thousands of mitochondria, known as 'powerhouses' for the energy they provide. But gene mutations can cause these important organelles to fail, often resulting in devastating disease. Erica Westly reports on the patient advocates—and politicians—pushing for new treatments for mitochondrial disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Giles, R.E., Blanc, H., Cann, H.M. & Wallace, D.C. Proc. Natl. Acad. Sci. USA. 77, 6715–6719 (1980).
Elliott, H.R., Samuels, D.C., Eden, J.A., Relton, C.L. & Chinnery, P.F. Am. J. Hum. Genet. 83, 254–260 (2008).
Schiff, M. et al. J. Inherit. Metab. Dis. 32, 684–698 (2009).
Schapira, A.H.V. Lancet Neurol. 7, 97–109 (2008).
Tachibana, M. et al. Nature 461, 367–372 (2009).
Craven, L. et al., Nature 465, 82–85 (2010).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Westly, E. When powerhouses fail. Nat Med 16, 625–627 (2010). https://doi.org/10.1038/nm0610-625
Issue Date:
DOI: https://doi.org/10.1038/nm0610-625
